Patent details

LUC00083 Product Name: Bictegravir or a pharmaceutically acceptable salt thereof, in particular bictegravir sodium

Basic Information

Publication number:
LUC00083
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP138159371
Legal Status:
Inactive
Application number:
LUC00083
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1289
Marketing Authorization Type:
Marketing Authorization Date:
25/06/2018
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
17/08/2018
First Marketing Authorization date:
25/06/2018
Grant date:
15/10/2018
Activation date:
Publication date:
22/08/2018
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
25/06/2033
SPC Extension Expiration:
25/06/2033
Rejection date:
Withdrawal date:

Owner

From:
17/08/2018
 
 

Name:
Gilead Sciences Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
17/08/2018
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2018/10
Publication date:
19/09/2018
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2018/12
Publication date:
15/11/2018
Description:
Section D : Granted supplementary protection certificates – I2 publication
Filing date Document type Number of pages
22/08/2018 Outgoing Correspondence 1
22/08/2018 Publication 1
17/08/2018 General Document 5
17/08/2018 General Document 11
17/08/2018 General Document 38
15/10/2018 Publication 1
17/08/2018 General Document 3
17/08/2018 Application Form 5
17/08/2018 General Document 2
15/10/2018 Certificate 1